{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:53:52Z","timestamp":1791075232772,"version":"4.1.0"},"reference-count":70,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000182","name":"Medical Research and Materiel Command","doi-asserted-by":"publisher","award":["W81XWH-07-2- 067"],"award-info":[{"award-number":["W81XWH-07-2- 067"]}],"id":[{"id":"10.13039\/100000182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1DP1DA034787-01"],"award-info":[{"award-number":["1DP1DA034787-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3DA048351"],"award-info":[{"award-number":["UG3DA048351"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Active immunization is an emerging potential modality to combat fatal overdose amid the opioid epidemic. In this study, we described the design, synthesis, formulation, and animal testing of an efficacious vaccine against fentanyl. The vaccine formulation is composed of a novel fentanyl hapten conjugated to tetanus toxoid (TT) and adjuvanted with liposomes containing monophosphoryl lipid A adsorbed on aluminum hydroxide. The linker and hapten N-phenyl-N-(1-(4-(3-(tritylthio)propanamido)phenethyl)piperidin-4-yl)propionamide were conjugated sequentially to TT using amine-N-hydroxysuccinimide-ester and thiol\u2013maleimide reaction chemistries, respectively. Conjugation was facile, efficient, and reproducible with a protein recovery of &amp;gt;98% and a hapten density of 30\u201335 per carrier protein molecule. In mice, immunization induced high and robust antibody endpoint titers in the order of &amp;gt;106 against the hapten. The antisera bound fentanyl, carfentanil, cyclopropyl fentanyl, para-fluorofentanyl, and furanyl fentanyl in vitro with antibody-drug dissociation constants in the range of 0.36\u20134.66 nM. No cross-reactivity to naloxone, naltrexone, methadone, or buprenorphine was observed. In vivo, immunization shifted the antinociceptive dose\u2013response curve of fentanyl to higher doses. Collectively, these preclinical results showcased the desired traits of a potential vaccine against fentanyl and demonstrated the feasibility of immunization to combat fentanyl-induced effects.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.0c00497","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T21:06:17Z","timestamp":1596143177000},"page":"3447-3460","source":"Crossref","is-referenced-by-count":40,"title":["Novel Vaccine That Blunts Fentanyl Effects and Sequesters\nUltrapotent Fentanyl Analogues"],"prefix":"10.1021","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-5047","authenticated-orcid":true,"given":"Rodell C.","family":"Barrientos","sequence":"first","affiliation":[{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , , 6720A Rockledge Drive , , ,","place":["Bethesda, Maryland, United States, 20817"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric W.","family":"Bow","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 9800 Medical Center Drive , , ,","place":["Bethesda, Maryland, United States, 20892-3373"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Whalen","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar B.","family":"Torres","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , , 6720A Rockledge Drive , , ,","place":["Bethesda, Maryland, United States, 20817"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Sulima","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 9800 Medical Center Drive , , ,","place":["Bethesda, Maryland, United States, 20892-3373"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Beck","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine , , 6720A Rockledge Drive , , ,","place":["Bethesda, Maryland, United States, 20817"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur E.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 9800 Medical Center Drive , , ,","place":["Bethesda, Maryland, United States, 20892-3373"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[{"name":"National Institutes of Health , , 9800 Medical Center Drive , , ,","place":["Bethesda, Maryland, United States, 20892-3373"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2074-2373","authenticated-orcid":true,"given":"Gary R.","family":"Matyas","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute of Research , , 503 Robert Grant Avenue , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"2026090403140061800_cit1","doi-asserted-by":"publisher","first-page":"j4355","DOI":"10.1136\/bmj.j4355","article-title":"Epidemic of deaths\nfrom fentanyl overdose","volume":"358","author":"Soci\u0301as","year":"2017","journal-title":"Br. Med. J."},{"key":"2026090403140061800_cit2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/nejmsr1706626","article-title":"The Role of Science in Addressing the Opioid Crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"2026090403140061800_cit3","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41398-019-0625-0","article-title":"The rising\ncrisis of illicit fentanyl use, overdose, and potential therapeutic\nstrategies","volume":"9","author":"Han","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"2026090403140061800_cit4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1001\/jama.2017.13358","article-title":"Reframing\nthe Opioid\nEpidemic as a National Emergency","volume":"318","author":"Gostin","year":"2017","journal-title":"JAMA, J. Am.\nMed. Assoc."},{"key":"2026090403140061800_cit5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and\nOpioid-Involved Overdose Deaths\u2500United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"2026090403140061800_cit6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl\nanalogs and novel synthetic opioids: A comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"2026090403140061800_cit7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: Receptor\npharmacology, abuse potential, and\nimplications for treatment","volume":"106","author":"Comer","year":"2019","journal-title":"Neurosci. Biobehav.\nRev."},{"key":"2026090403140061800_cit8","volume-title":"The Future of Fentanyl\nand Other Synthetic\nOpioids","author":"Bryce","year":"2019"},{"key":"2026090403140061800_cit9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/20961790.2018.1460063","article-title":"Fatalities\ncaused by novel opioids: a review","volume":"4","author":"Drummer","year":"2018","journal-title":"Forensic\nSci. Prog."},{"key":"2026090403140061800_cit10","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fphar.2018.01210","article-title":"Postmortem Toxicology\nof New Synthetic Opioids","volume":"9","author":"Concheiro","year":"2018","journal-title":"Front. Pharmacol."},{"key":"2026090403140061800_cit11","doi-asserted-by":"publisher","first-page":"e662","DOI":"10.1093\/milmed\/usz487","article-title":"The Opioid Epidemic:\nChallenge to\nMilitary Medicine and National Security","volume":"185","author":"Dembek","year":"2020","journal-title":"Mil.\nMed."},{"key":"2026090403140061800_cit12","first-page":"1","article-title":"Fentanyl\nas a Chemical Weapon","volume-title":"CSWMD Proceedings","author":"Caves","year":"2019"},{"key":"2026090403140061800_cit13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drugpo.2009.02.007","article-title":"HIV infection and risk behaviour\nof primary fentanyl\nand amphetamine injectors in Tallinn, Estonia: implications for intervention","volume":"21","author":"Talu","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"2026090403140061800_cit14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.drugpo.2019.10.004","article-title":"Associations\nbetween perceived illicit fentanyl use\nand infectious disease risks among people who inject drugs","volume":"74","author":"Lambdin","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"2026090403140061800_cit15","unstructured":"World Drug Report. https:\/\/wdr.unodc.org\/wdr2019\/en\/exsum.html (June 19, 2020)."},{"key":"2026090403140061800_cit16","unstructured":"Center for Disease Control and Prevention.\n          . Estimated HIV\nincidence and prevalence in the United States, 2014\u20132018.  HIV Surveillance Supplemental Report, 2020; Vol. 25 (1)."},{"key":"2026090403140061800_cit17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/mlr.0000000000000625","article-title":"The Economic Burden\nof Prescription Opioid Overdose, Abuse, and Dependence in the United\nStates, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Med. Care"},{"key":"2026090403140061800_cit18","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/s0140-6736(18)33078-2","article-title":"Management of opioid use disorder\nin the USA: present\nstatus and future directions","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"key":"2026090403140061800_cit19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1186\/s12913-019-4751-4","article-title":"Opioid use disorder and treatment:\nchallenges and opportunities","volume":"19","author":"Hoffman","year":"2019","journal-title":"BMC Health Serv.\nRes."},{"key":"2026090403140061800_cit20","doi-asserted-by":"publisher","first-page":"e1916271","DOI":"10.1001\/jamanetworkopen.2019.16271","article-title":"Trends and\nRapidity\nof Dose Tapering Among Patients Prescribed Long-term Opioid Therapy,\n2008-2017","volume":"2","author":"Fenton","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"2026090403140061800_cit21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence\nand clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther. Adv. Drug Saf."},{"key":"2026090403140061800_cit22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13011-019-0195-4","article-title":"Higher doses of naloxone are needed\nin the synthetic\nopioid era","volume":"14","author":"Moss","year":"2019","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"2026090403140061800_cit23","doi-asserted-by":"publisher","first-page":"411.e5","DOI":"10.1016\/j.ajem.2019.09.009","article-title":"Wooden chest syndrome:\nBeware of\nopioid antagonists, not just agonists","volume":"38","author":"Levine","year":"2020","journal-title":"Am. J.\nEmerg. Med."},{"key":"2026090403140061800_cit24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15252\/embr.201745322","article-title":"Vaccines to combat\nthe opioid crisis: Vaccines that\nprevent opioids and other substances of abuse from entering the brain\ncould effectively treat addiction and abuse","volume":"19","author":"Olson","year":"2018","journal-title":"EMBO Rep."},{"key":"2026090403140061800_cit25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1124\/pr.117.013904","article-title":"Conjugate Vaccine\nImmunotherapy for Substance Use Disorder","volume":"69","author":"Bremer","year":"2017","journal-title":"Pharmacol.\nRev."},{"key":"2026090403140061800_cit26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41386-018-0197-3","article-title":"Vaccines to\ntreat opioid use disorders and to reduce\nopioid overdoses","volume":"44","author":"Baehr","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"2026090403140061800_cit27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-3-319-23150-1_20","article-title":"Practical Considerations\nfor the Development of Vaccines Against Drugs of Abuse","volume-title":"Biologics to Treat Substance Use Disorders: Vaccines,\nMonoclonal Antibodies, and Enzymes","author":"Torres","year":"2016"},{"key":"2026090403140061800_cit28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4161\/hv.22060","article-title":"Nicotine vaccines\nto treat tobacco dependence","volume":"9","author":"Goniewicz","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"2026090403140061800_cit29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.drugalcdep.2017.03.005","article-title":"Effective\nactive vaccination against methamphetamine in female rats","volume":"175","author":"Nguyen","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"2026090403140061800_cit30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1586\/erv.10.102","article-title":"Anti-cocaine\nvaccine development","volume":"9","author":"Kinsey","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"2026090403140061800_cit31","doi-asserted-by":"publisher","first-page":"e0184876","DOI":"10.1371\/journal.pone.0184876","article-title":"Safety and efficacy of an oxycodone vaccine: Addressing\nsome of the unique considerations posed by opioid abuse","volume":"12","author":"Raleigh","year":"2017","journal-title":"PLoS One"},{"key":"2026090403140061800_cit32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1021\/acs.jmedchem.7b01427","article-title":"A Stable Heroin Analogue That Can\nServe as a Vaccine Hapten to Induce Antibodies That Block the Effects\nof Heroin and Its Metabolites in Rodents and That Cross-React Immunologically\nwith Related Drugs of Abuse","volume":"61","author":"Sulima","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026090403140061800_cit33","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1021\/acschemneuro.8b00079","article-title":"Efficacious Vaccine\nagainst Heroin Contaminated with\nFentanyl","volume":"9","author":"Hwang","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"2026090403140061800_cit34","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41386-019-0385-9","article-title":"Conjugate\nvaccine produces long-lasting attenuation of fentanyl vs. food choice\nand blocks expression of opioid withdrawal-induced increases in fentanyl\nchoice in rats","volume":"44","author":"Townsend","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"2026090403140061800_cit35","doi-asserted-by":"publisher","first-page":"107730","DOI":"10.1016\/j.neuropharm.2019.107730","article-title":"Vaccine blunts fentanyl\npotency in male rhesus monkeys","volume":"158","author":"Tenney","year":"2019","journal-title":"Neuropharmacology"},{"key":"2026090403140061800_cit36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1124\/jpet.118.253674","article-title":"A Fentanyl\nVaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced\nEffects in Mice and Rats","volume":"368","author":"Raleigh","year":"2019","journal-title":"J. Pharmacol. Exp.\nTher."},{"key":"2026090403140061800_cit37","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting\nSynthetic Designer Opioids: A Conjugate\nVaccine Ablates Lethal Doses of Fentanyl Class Drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026090403140061800_cit38","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1021\/acschemneuro.0c00064","article-title":"Evaluation of a\nDual Fentanyl\/Heroin Vaccine on the Antinociceptive and Reinforcing\nEffects of a Fentanyl\/Heroin Mixture in Male and Female Rats","volume":"11","author":"Townsend","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"2026090403140061800_cit39","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1124\/jpet.117.247049","article-title":"Opioid Dose- and Route-Dependent\nEfficacy of Oxycodone and Heroin Vaccines in Rats","volume":"365","author":"Raleigh","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2026090403140061800_cit40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14760584.2020.1745636","article-title":"Army Liposome\nFormulation (ALF) family of vaccine adjuvants","volume":"19","author":"Alving","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"2026090403140061800_cit41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/s0076-6879(03)73003-1","article-title":"Oil-in-water\nliposomal emulsions\nfor vaccine delivery","volume":"373","author":"Matyas","year":"2003","journal-title":"Methods Enzymol."},{"key":"2026090403140061800_cit42","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1016\/j.vaccine.2013.04.027","article-title":"Liposomes containing\nmonophosphoryl lipid A: a potent\nadjuvant system for inducing antibodies to heroin hapten analogs","volume":"31","author":"Matyas","year":"2013","journal-title":"Vaccine"},{"key":"2026090403140061800_cit43","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1021\/jm00378a008","article-title":"Probes\nfor narcotic receptor mediated\nphenomena. 7. Synthesis and pharmacological properties of irreversible\nligands specific for mu or delta opiate receptors","volume":"27","author":"Burke","year":"1984","journal-title":"J. Med. Chem."},{"key":"2026090403140061800_cit44","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1007\/s00216-014-8035-x","article-title":"Characterization and optimization\nof heroin hapten-BSA conjugates: method development for the synthesis\nof reproducible hapten-based vaccines","volume":"406","author":"Torres","year":"2014","journal-title":"Anal.\nBioanal. Chem."},{"key":"2026090403140061800_cit45","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/978-1-4939-3387-7_39","article-title":"Synthesis\nof Hapten-Protein Conjugate\nVaccines with Reproducible Hapten Densities","volume":"1403","author":"Torres","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"2026090403140061800_cit46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jconrel.2018.02.006","article-title":"Immune\nresponse to antigen adsorbed to aluminum hydroxide particles: Effects\nof co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex","volume":"275","author":"Beck","year":"2018","journal-title":"J. Controlled Release"},{"key":"2026090403140061800_cit47","unstructured":"Guide for the Care and Use of Laboratory Animals; National Academies Press (US), National Academy\nof Sciences: Washington (DC), 2011."},{"key":"2026090403140061800_cit48","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1021\/acs.bioconjchem.5b00085","article-title":"Efficacy,\nbut not\nantibody titer or affinity, of a heroin hapten conjugate vaccine correlates\nwith increasing hapten densities on tetanus toxoid, but not on CRM197\ncarriers","volume":"26","author":"Jalah","year":"2015","journal-title":"Bioconjugate Chem."},{"key":"2026090403140061800_cit49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"2026090403140061800_cit50","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00216-015-9223-z","article-title":"A simple nonradioactive\nmethod for the determination of the binding affinities of antibodies\ninduced by hapten bioconjugates for drugs of abuse","volume":"408","author":"Torres","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"2026090403140061800_cit51","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0076-6879(83)92046-3","article-title":"Determination\nof affinity and specificity of anti-hapten antibodies by competitive\nradioimmunoassay","volume":"92","author":"Mu\u0308ller","year":"1983","journal-title":"Methods Enzymol."},{"key":"2026090403140061800_cit52","volume-title":"Fitting Models to Biological\nData Using Linear and Nonlinear Regression","author":"Motulsky","year":"2003"},{"key":"2026090403140061800_cit53","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.vaccine.2014.01.028","article-title":"Facial recognition of heroin vaccine\nopiates: type 1 cross-reactivities of antibodies induced by hydrolytically\nstable haptenic surrogates of heroin, 6-acetylmorphine, and morphine","volume":"32","author":"Matyas","year":"2014","journal-title":"Vaccine"},{"key":"2026090403140061800_cit54","doi-asserted-by":"publisher","first-page":"e96547","DOI":"10.1371\/journal.pone.0101807","article-title":"Effect of currently\napproved carriers and adjuvants\non the pre-clinical efficacy of a conjugate vaccine against oxycodone\nin mice and rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"key":"2026090403140061800_cit55","doi-asserted-by":"publisher","first-page":"11537","DOI":"10.1021\/acsomega.8b01478","article-title":"Improved Admixture Vaccine of Fentanyl and Heroin Hapten\nImmunoconjugates: Antinociceptive Evaluation of Fentanyl-Contaminated\nHeroin","volume":"3","author":"Hwang","year":"2018","journal-title":"ACS Omega"},{"key":"2026090403140061800_cit56","unstructured":"TDVAX.\n          . https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/tdvax (accessed on Feb 8, 2020)."},{"key":"2026090403140061800_cit57","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3762\/bjoc.15.100","article-title":"A chemically contiguous hapten approach for a heroin-fentanyl\nvaccine","volume":"15","author":"Natori","year":"2019","journal-title":"Beilstein J. Org. Chem."},{"key":"2026090403140061800_cit58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuroscience.2011.12.041","article-title":"Tests and\nmodels of nociception and pain in rodents","volume":"211","author":"Barrot","year":"2012","journal-title":"Neuroscience"},{"key":"2026090403140061800_cit59","doi-asserted-by":"publisher","first-page":"10489","DOI":"10.1021\/jacs.9b04872","article-title":"Monoclonal\nAntibodies for Combating\nSynthetic Opioid Intoxication","volume":"141","author":"Smith","year":"2019","journal-title":"J. Am. Chem.\nSoc."},{"key":"2026090403140061800_cit60","unstructured":"Fentanyl Drug Profile.\n          . http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/fentanyl (accessed on Feb 8, 2020)."},{"key":"2026090403140061800_cit61","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fphar.2019.00238","article-title":"Metabolic Pathways\nand Potencies of New Fentanyl Analogs","volume":"10","author":"Wilde","year":"2019","journal-title":"Front.\nPharmacol."},{"key":"2026090403140061800_cit62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11419-007-0039-1","article-title":"Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine\n(fentanyl) and its related compounds. VI. Structure-analgesic activity\nrelationship for fentanyl, methyl-substituted fentanyls and other\nanalogues","volume":"26","author":"Higashikawa","year":"2008","journal-title":"Forensic Toxicol."},{"key":"2026090403140061800_cit63","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/jat\/bky035","article-title":"Analysis of Fentanyl\nand 18 Novel\nFentanyl Analogs and Metabolites by LC-MS-MS, and report of Fatalities\nAssociated with Methoxyacetylfentanyl and Cyclopropylfentanyl","volume":"42","author":"Fogarty","year":"2018","journal-title":"J. Anal. Toxicol."},{"key":"2026090403140061800_cit64","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jat\/bkw086","article-title":"Analysis of Novel\nSynthetic Opioids U-47700, U-50488\nand Furanyl Fentanyl by LC-MS\/MS in Postmortem Casework","volume":"40","author":"Mohr","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"2026090403140061800_cit65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/jat\/bkx052","article-title":"An LC-MS-MS\nMethod for the Analysis of Carfentanil, 3-Methylfentanyl, 2-Furanyl\nFentanyl, Acetyl Fentanyl, Fentanyl and Norfentanyl in Postmortem\nand Impaired-Driving Cases","volume":"41","author":"Sofalvi","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"2026090403140061800_cit66","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/jat\/bkw129","article-title":"Postmortem\nand Toxicological Findings in a Series of Furanylfentanyl-Related\nDeaths","volume":"41","author":"Guerrieri","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"2026090403140061800_cit67","doi-asserted-by":"publisher","first-page":"676","DOI":"10.23907\/2015.072","article-title":"Postmortem Toxicology Findings of\nAcetyl Fentanyl, Fentanyl, and Morphine in Heroin Fatalities in Tampa,\nFlorida","volume":"5","author":"Pearson","year":"2015","journal-title":"Acad Forensic Pathol."},{"key":"2026090403140061800_cit68","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fimmu.2013.00302","article-title":"The structural basis of antibody-antigen\nrecognition","volume":"4","author":"Sela-Culang","year":"2013","journal-title":"Front. Immunol."},{"key":"2026090403140061800_cit69","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1016\/j.vaccine.2019.05.061","article-title":"Heroin vaccine:\nUsing titer, affinity, and antinociception\nas metrics when examining sex and strain differences","volume":"37","author":"Hwang","year":"2019","journal-title":"Vaccine"},{"key":"2026090403140061800_cit70","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0022-3565(24)36831-4","article-title":"Sex-related\ndifferences in morphine\u2019s\nantinociceptive activity: relationship to serum and brain morphine\nconcentrations","volume":"282","author":"Cicero","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.0c00497","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/17\/9\/3447\/67342133\/acs.molpharmaceut.0c00497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/17\/9\/3447\/67342133\/acs.molpharmaceut.0c00497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:26:31Z","timestamp":1788510391000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/17\/9\/3447\/508015\/Novel-Vaccine-That-Blunts-Fentanyl-Effects-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":70,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,7,30]]},"published-print":{"date-parts":[[2020,9,8]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00497","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]}}}